Analyze Diet
The Veterinary record2016; 178(23); 585; doi: 10.1136/vr.103609

Evaluation of 10-minute versus 30-minute tourniquet time for intravenous regional limb perfusion with amikacin sulfate in standing sedated horses.

Abstract: The objective of the article is to determine the synovial fluid concentrations of amikacin sulfate (AS) after performing an intravenous regional limb perfusion (IVRLP) with the tourniquet in place for 10 minutes and compare this with 30 minutes. This is a randomised crossover experimental design. Animals were seven healthy adult horses. Horses underwent two IVRLP procedures in a randomised, crossover design. The horses received IVRLP with 2 g AS diluted to 60 ml using 0.9% saline in the cephalic vein of alternate limbs with the tourniquet in place for either 10 or 30 minutes, with a washout period between procedures. Movement of the horses was recorded. Synovial fluid was collected from the radiocarpal and metacarpophalangeal joints at five minutes and 24 hours after IVRLP, and amikacin concentration was compared between groups. Amikacin was quantified by a fluorescence polarisation immunoassay. There was no significant difference between the synovial amikacin concentrations noted between 10 minute and 30 minute IVRLP. Horses in the 30 minute tourniquet application group demonstrated more movement than the 10 minute tourniquet group. There was a significant difference between groups with regard to the systemic venous blood concentration of amikacin one minute after tourniquet release with mean systemic venous blood concentrations of AS being higher (P=0.001) in the 10 minute group. Ten minute application of a wide elastic tourniquet may be sufficient when performing IVRLP in standing sedated horses.
Publication Date: 2016-04-13 PubMed ID: 27076528DOI: 10.1136/vr.103609Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research evaluates if a 10-minute application of a tourniquet during intravenous regional limb perfusion in horses yields similar results to a 30-minute application when administering amikacin sulfate, an antimicrobial drug.

Research Methodology and Design

The research uses a randomised crossover experimental design on seven healthy adult horses. The horses underwent two distinct intravenous regional limb perfusion (IVRLP) procedures, each with different tourniquet times of 10 minutes and 30 minutes.

  • Each horse was sedated and administered 2g of amikacin sulfate (AS) diluted to 60 ml using 0.9% saline injected into the cephalic vein of alternating limbs.
  • A washout period was applied between the procedures to allow for the elimination of the drug from the system before conducting the alternative procedure.
  • The movements of the horses were observed and recorded.

Data Collection and Analysis

The researchers harvested synovial fluid from the radiocarpal and metacarpophalangeal joints at five minutes and 24 hours after the IVRLP procedure. The amikacin concentration in the synovial fluid was then compared between the two groups.

  • A fluorescence polarization immunoassay technique was used for the amikacin concentration quantification.
  • Data from the movement recordings was also analysed.

Findings & Conclusion

There was no significant difference in the concentration of amikacin in the synovial fluid between the 10-minute and 30-minute tourniquet group. However, more movement was observed in horses from the 30-minute application group.

  • This indicates that the additional tourniquet time could potentially bring about discomfort leading to increased movement in the horses.
  • The systemic venous blood concentration of amikacin one minute after tourniquet release was higher in the 10-minute group which was statistically significant (P=0.001).

The study concludes that a 10-minute application of a wide elastic tourniquet may be sufficient for IVRLP in standing sedated horses, which minimizes discomfort and yields similar drug concentrations in the synovial fluid.

Cite This Article

APA
Kilcoyne I, Dechant JE, Nieto JE. (2016). Evaluation of 10-minute versus 30-minute tourniquet time for intravenous regional limb perfusion with amikacin sulfate in standing sedated horses. Vet Rec, 178(23), 585. https://doi.org/10.1136/vr.103609

Publication

ISSN: 2042-7670
NlmUniqueID: 0031164
Country: England
Language: English
Volume: 178
Issue: 23
Pages: 585

Researcher Affiliations

Kilcoyne, I
  • Veterinary Medical Teaching Hospital, UC Davis School of Veterinary Medicine, Davis, California, USA.
Dechant, J E
  • Department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine, Davis, California, USA.
Nieto, J E
  • Department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine, Davis, California, USA.

MeSH Terms

  • Amikacin / administration & dosage
  • Amikacin / analysis
  • Animals
  • Conscious Sedation / veterinary
  • Cross-Over Studies
  • Forelimb / blood supply
  • Horses
  • Perfusion / methods
  • Perfusion / veterinary
  • Posture
  • Regional Blood Flow
  • Synovial Fluid / chemistry
  • Time Factors
  • Tourniquets / statistics & numerical data
  • Tourniquets / veterinary

Citations

This article has been cited 2 times.
  1. Redding LE, Elzer EJ, Ortved KF. Effects of regional limb perfusion technique on concentrations of antibiotic achieved at the target site: A meta-analysis.. PLoS One 2022;17(4):e0265971.
    doi: 10.1371/journal.pone.0265971pubmed: 35363825google scholar: lookup
  2. Bonilla AG, Causeret L, Torrent-Crosa A. Pharmacokinetics of ceftiofur in the metacarpophalangeal joint after standing intravenous regional limb perfusion in horses.. Can Vet J 2021 Sep;62(9):975-981.
    pubmed: 34475583